SE9700708L - Oralt preparat för profylaktisk och terapeutisk behandling av helicobacter sp. infektion - Google Patents

Oralt preparat för profylaktisk och terapeutisk behandling av helicobacter sp. infektion

Info

Publication number
SE9700708L
SE9700708L SE9700708A SE9700708A SE9700708L SE 9700708 L SE9700708 L SE 9700708L SE 9700708 A SE9700708 A SE 9700708A SE 9700708 A SE9700708 A SE 9700708A SE 9700708 L SE9700708 L SE 9700708L
Authority
SE
Sweden
Prior art keywords
oral preparation
preparation
prophylactic
infection
therapeutic treatment
Prior art date
Application number
SE9700708A
Other languages
Unknown language ( )
English (en)
Other versions
SE522246C2 (sv
SE9700708D0 (sv
Inventor
Torkel Wadstroem
Por Alejung
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to SE9700708A priority Critical patent/SE522246C2/sv
Publication of SE9700708D0 publication Critical patent/SE9700708D0/sv
Priority to CN98802850A priority patent/CN1119994C/zh
Priority to CA002280715A priority patent/CA2280715C/en
Priority to JP53722298A priority patent/JP4267076B2/ja
Priority to KR1019997007239A priority patent/KR100569908B1/ko
Priority to IL13112998A priority patent/IL131129A/en
Priority to EP98906921A priority patent/EP0981338B1/en
Priority to AU62951/98A priority patent/AU719090B2/en
Priority to US09/367,838 priority patent/US6262316B1/en
Priority to PL98335370A priority patent/PL335370A1/xx
Priority to NZ337080A priority patent/NZ337080A/en
Priority to DE69815677T priority patent/DE69815677D1/de
Priority to AT98906921T priority patent/ATE243030T1/de
Priority to PCT/EP1998/000628 priority patent/WO1998037874A1/en
Publication of SE9700708L publication Critical patent/SE9700708L/sv
Priority to NO19994109A priority patent/NO327303B1/no
Publication of SE522246C2 publication Critical patent/SE522246C2/sv
Priority to JP2006032853A priority patent/JP4463773B2/ja
Priority to JP2009295816A priority patent/JP2010111689A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)
SE9700708A 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion SE522246C2 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion
PCT/EP1998/000628 WO1998037874A1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
US09/367,838 US6262316B1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp. infection
NZ337080A NZ337080A (en) 1997-02-27 1998-02-05 Oral preparation containing xanthophylles such as astaxanthin to helicobacter sp.infection
JP53722298A JP4267076B2 (ja) 1997-02-27 1998-02-05 Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤
KR1019997007239A KR100569908B1 (ko) 1997-02-27 1998-02-05 헬리코박터 에스피 감염의 예방 및 치료에 사용되는 경구용제제
IL13112998A IL131129A (en) 1997-02-27 1998-02-05 An oral preparation for the prevention and treatment of infection caused by the Helicobacter strain
EP98906921A EP0981338B1 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
AU62951/98A AU719090B2 (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp. infection
CN98802850A CN1119994C (zh) 1997-02-27 1998-02-05 用于预防和治疗螺杆菌属感染的口服制剂
PL98335370A PL335370A1 (en) 1997-02-27 1998-02-05 Orally administered preparation for preventing and treating bacterial infections caused by helicobacter sp.
CA002280715A CA2280715C (en) 1997-02-27 1998-02-05 Oral preparation for the prophylactic and therapeutic treatment of helicobacter sp.infection
DE69815677T DE69815677D1 (de) 1997-02-27 1998-02-05 Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
AT98906921T ATE243030T1 (de) 1997-02-27 1998-02-05 Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
NO19994109A NO327303B1 (no) 1997-02-27 1999-08-25 Anvendelse av astaxanthin for fremstilling av et preparat for profylaktisk og terapeutisk behandling av Helicobacter sp.-infeksjon
JP2006032853A JP4463773B2 (ja) 1997-02-27 2006-02-09 Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤
JP2009295816A JP2010111689A (ja) 1997-02-27 2009-12-25 Ｈｅｌｉｃｏｂａｃｔｅｒ種による感染症の予防および治療用経口製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Publications (3)

Publication Number Publication Date
SE9700708D0 SE9700708D0 (sv) 1997-02-27
SE9700708L true SE9700708L (sv) 1998-08-28
SE522246C2 SE522246C2 (sv) 2004-01-27

Family

ID=20405957

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700708A SE522246C2 (sv) 1997-02-27 1997-02-27 Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Country Status (15)

Country Link
US (1) US6262316B1 (sv)
EP (1) EP0981338B1 (sv)
JP (3) JP4267076B2 (sv)
KR (1) KR100569908B1 (sv)
CN (1) CN1119994C (sv)
AT (1) ATE243030T1 (sv)
AU (1) AU719090B2 (sv)
CA (1) CA2280715C (sv)
DE (1) DE69815677D1 (sv)
IL (1) IL131129A (sv)
NO (1) NO327303B1 (sv)
NZ (1) NZ337080A (sv)
PL (1) PL335370A1 (sv)
SE (1) SE522246C2 (sv)
WO (1) WO1998037874A1 (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE524337C2 (sv) * 1998-10-16 2004-07-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7078040B2 (en) 2000-03-27 2006-07-18 Fuji Chemical Industry Co., Ltd. Method of inhibiting the expression of inflammatory cytokines and chemokines
SE0001071D0 (sv) * 2000-03-27 2000-03-27 Astacarotene Ab Method of inhibiting the expression of inflammatory cytokines and chemokines
KR100481880B1 (ko) * 2001-12-05 2005-04-11 (주)바이오벤 목이버섯으로부터 헬리코박터 파이로리의 부착억제성분을추출하는 방법 및 그 헬리코박터 파이로리의 부착억제성분
CA2473698A1 (en) * 2002-01-16 2003-07-31 Natural Alternatives International, Inc. Anti-inflammatory formulations
AU2002329108A1 (en) * 2002-09-03 2004-03-29 Centro De Investigacion En Alimentacion Y Desarrollo A.C. Method of preparing chitosan microcapsules of astaxanthin and product thus obtained
US20040151761A1 (en) * 2003-02-05 2004-08-05 The Procter & Gamble Company Methods and compositions utilizing astaxanthin
GB0314624D0 (en) 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
WO2005025586A1 (en) 2003-09-12 2005-03-24 Access Business Group International Llc Cytokine modulators and related method of use
US20070128310A1 (en) 2003-12-19 2007-06-07 Meni-One Co., Ltd. Astaxanthin-containing pet foods
WO2005102356A1 (en) 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
CN1324989C (zh) * 2005-10-10 2007-07-11 华南理工大学 含虾青素营养食品及其制备方法
US20090118227A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
JP5497372B2 (ja) * 2009-08-19 2014-05-21 バイオジェニック株式会社 非ステロイド性抗炎症薬起因性潰瘍の予防・治療薬
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
CN107691751A (zh) * 2017-11-12 2018-02-16 张雅萍 一种美容、香体的虾青素夹心凝胶糖果及其制备方法
US11065269B1 (en) * 2018-11-15 2021-07-20 Samuel L. Shepherd Method of using astaxanthin for the treatment of diseases, and more particularly, the treatment of cancer
CN114732130B (zh) * 2022-04-07 2024-01-23 云南雨藻生物科技有限公司 含雨生红球藻且抑制胃粘膜受损的组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH0799924A (ja) 1993-09-30 1995-04-18 Nippon Suisan Kaisha Ltd アスタキサンチンを主要成分とするファフィア色素油の安定な粉末化物及びその製造方法
JPH07300421A (ja) * 1994-04-28 1995-11-14 Itano Reitou Kk 抗炎症剤
US5886053A (en) * 1995-02-03 1999-03-23 Basf Aktiengesellschaft Use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物

Also Published As

Publication number Publication date
CN1248912A (zh) 2000-03-29
CA2280715C (en) 2008-10-07
CN1119994C (zh) 2003-09-03
EP0981338B1 (en) 2003-06-18
JP2006188526A (ja) 2006-07-20
DE69815677D1 (de) 2003-07-24
KR100569908B1 (ko) 2006-04-10
JP2010111689A (ja) 2010-05-20
JP4267076B2 (ja) 2009-05-27
NO327303B1 (no) 2009-06-02
EP0981338A1 (en) 2000-03-01
IL131129A (en) 2004-06-20
AU719090B2 (en) 2000-05-04
WO1998037874A1 (en) 1998-09-03
NO994109L (no) 1999-10-27
ATE243030T1 (de) 2003-07-15
CA2280715A1 (en) 1998-09-03
NZ337080A (en) 2001-03-30
PL335370A1 (en) 2000-04-25
AU6295198A (en) 1998-09-18
SE522246C2 (sv) 2004-01-27
SE9700708D0 (sv) 1997-02-27
IL131129A0 (en) 2001-01-28
JP2001517213A (ja) 2001-10-02
KR20000070973A (ko) 2000-11-25
US6262316B1 (en) 2001-07-17
JP4463773B2 (ja) 2010-05-19
NO994109D0 (no) 1999-08-25

Similar Documents

Publication Publication Date Title
SE9700708L (sv) Oralt preparat för profylaktisk och terapeutisk behandling av helicobacter sp. infektion
EP1370564B1 (en) Resveratrol-phospholipids complexes
EP1765324A2 (en) Compositions of stable bioactive metabolites of docosahexaenoic (dha) and eicosapentaenoic (epa) acids
AU600904B2 (en) Composition for the treatment of acne
SE9704693L (sv) Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
JPH0657659B2 (ja) 消化管にて種々のレベルで消化促進剤として作用する酵素組成物
DE69918152D1 (de) Behandlung von verdauungsstörungen
ES2251948T3 (es) Preparacion de un medicamento que contiene compuestos polifenolicos de tipo catequico o flavonicos de origen vegetal, en particular para el tratamiento de las gingivitis.
WO2007116432A1 (ja) キャノロールまたはそのプロドラッグ（ｐｄ）を含む抗炎症剤および癌予防剤ならびにこれらを含む医薬、化粧品および食品
Chandrashekar Comparative Study on the Efficacy of Topical Curcumin as a Gel and as Buccal Mucoadhesive Patch in the Management of Oral Submucous Fibrosis-A Clinicobiochemical Evaluation
WO2008054293A1 (en) Composition, its use for treating systemic diseases a conditions, and product containing said composition
Blend TPPTM INFLAMMATORY CONTROL
Golhar et al. Astaxanthin-A Glimmer of Hope for Good Health
JP2004277301A (ja) リパーゼ阻害物質

Legal Events

Date Code Title Description
NUG Patent has lapsed